SCHEMBL8964346

SCHEMBL8964346

C=C(F)Cc1ccc(O)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 4/20 0.52
CAMK2A Q9UQM7 1/20 0.52
ESR1 P03372 4/20 0.50
ESR2 Q92731 2/20 0.50
FNTA P49354 1/20 0.46
FNTB P49356 1/20 0.46
ABAT P80404 1/20 0.46
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
IDO1 P14902 2/20 0.42
HTR1A P08908 1/20 0.42
ADRA2A P08913 1/20 0.42
SLC6A2 P23975 1/20 0.42
CYP2C19 P33261 1/20 0.42
HTR3A P46098 1/20 0.42
BACE1 P56817 1/20 0.42
TAAR1 Q96RJ0 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
MAPT P10636 2/20 0.42
HSD17B10 Q99714 2/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Anolignan B SCHEMBL23268876 0.81 CA2 (0.54) CA2CAMK2AESR1ESR2FNTA
SCHEMBL7735456 0.79 CA2 (0.52) CA2CAMK2AESR1ESR2FNTA
SCHEMBL7856390 0.79 CA2 (0.58) CA2CAMK2AESR1ESR2FNTA
SCHEMBL465583 0.77 CA2 (0.50) CA2CAMK2AESR1ESR2FNTA
SCHEMBL8858040 0.77 MEN1 (0.41) IDO1TAAR1L3MBTL1MAPTKMT2A
SCHEMBL20618816 0.77 IDO1 (0.44) ALDH1A1IDO1TAAR1L3MBTL1KMT2A
SCHEMBL8964637 0.77 IDO1 (0.50) CA2CAMK2AIDO1
SCHEMBL17124616 0.77 CA2 (0.50) CA2CAMK2AESR1ESR2FNTA
SCHEMBL8964597 0.77 CA2 (0.50) CA2CAMK2AESR1ESR2FNTA
SCHEMBL10535299 0.77 CA2 (0.60) CA2CAMK2AESR1ESR2FNTA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0410379-B1 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMA (US) 1996-01-31 EP claimed
US-5068465-A Hypotensive agents or enzyme inhibitors for treatment of hypertension MERRELL DOW PHARMACEUTICALS INC. (US) 1991-11-26 US claimed
EP-0410379-A2 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP claimed
EP-0410380-A2 Novel process for the synthesis of 2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP claimed
CN-104326916-A Combined preparation and application of 2-fluoro-4-allyl-6-nitrophenol and 2-fluoro-4-nitro-6-allyl phenol UNIV QINGDAO AGRICULTURAL 2015-02-04 CN disclosed
EP-0410379-B1 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMA (US) 1996-01-31 EP disclosed
US-5068465-A Hypotensive agents or enzyme inhibitors for treatment of hypertension MERRELL DOW PHARMACEUTICALS INC. (US) 1991-11-26 US disclosed
EP-0410379-A2 Pharmaceutically active 3-aryl and 3-heteroaryl-2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP disclosed
EP-0410380-A2 Novel process for the synthesis of 2-fluoro-1-olefins MERRELL DOW PHARMACEUTICALS INC. (US) 1991-01-30 EP disclosed
US-4981868-A ENZYME INHIBITORS, HYPOTENSIVES MERRELL DOW PHARMACEUTICAL (US) 1991-01-01 US disclosed